For the Quarter Ending June 2025
Asia-Pacific (APAC)
• The Magnesium Acetate Tetrahydrate Spot Price in China fluctuated mildly across Q2 2025, registering a decline in April (-1.34%) and May (-0.97%), followed by a marginal recovery in June (+0.98%), reaching USD 1030/MT.
• The Price Index movement in June indicated a cautious upward shift driven by exporter margin protection, despite muted global inquiries and moderate downstream activity.
• Throughout the quarter, the Magnesium Acetate Tetrahydrate Production Cost Trend was stable due to a gradual decline in acetic acid feedstock prices, allowing producers to maintain cost-efficiency.
• Production conditions across Chinese facilities remained uninterrupted, with throughput levels aligning closely with real-time demand volumes, preventing market saturation.
• Inventory buildup was observed during May and June due to a delayed response from international buyers, especially from pharmaceutical clients holding back restocking decisions.
• The Magnesium Acetate Tetrahydrate Demand Outlook in China stayed neutral to slightly soft, with stable pharmaceutical off-take and non-aggressive buying from nutraceutical and food additive sectors.
• Despite monsoon onset in some regions, China experienced seamless logistics in Q2 2025, with no disruptions in port operations or inland movement, further stabilizing trade flow.
• Exporters adopted short-cycle pricing tactics to stay competitive while limiting exposure to long-dated contracts, reflecting their tactical approach amid a flat demand cycle.
• Why did the price change in July 2025? Price Forecast for July 2025 suggests mild stability or a marginal increase as inventory normalizes and routine formulation procurement picks up ahead of seasonal uptick.
North America
• The Magnesium Acetate Tetrahydrate Spot Price in North America remained largely stable in Q2 2025, with no sharp movements due to aligned supply-demand ratios and contract-bound procurement from pharmaceutical manufacturers.
• The Price Index showed minimal fluctuations, reflecting subdued but consistent formulation demand and absence of major cost pressures or raw material constraints.
• The Magnesium Acetate Tetrahydrate Production Cost Trend remained neutral as U.S. producers benefited from steady access to domestic and imported acetic acid at controlled costs.
• Domestic production rates were balanced, with no signs of oversupply or capacity strain, helping suppliers meet steady contract volumes without pushing excess inventory into the spot market.
• Pharmaceutical demand remained consistent across Q2 due to uninterrupted formulation cycles and predictable orders from OTC and dermatological product manufacturers.
• The Magnesium Acetate Tetrahydrate Demand Outlook remained steady, aided by low-to-moderate growth in topical and supplement-based applications, although nutraceutical segment remained cautious.
• No logistical issues were observed; domestic freight costs were stable, and port entries for imported intermediate materials were processed without delays or cost surges.
• Suppliers focused on fulfilling quarterly contracts, minimizing exposure to spot market volatility while maintaining order visibility with legacy clients.
• Why did the price change in July 2025? The Price Forecast for July 2025 suggests marginal upward correction as formulation cycles intensify ahead of the fall demand season and buffer inventory procurement begins.
Europe
• The Magnesium Acetate Tetrahydrate Spot Price in Europe saw slight downward pressure in April and May due to subdued pharmaceutical formulation activity and reduced spot-level buying.
• The Price Index indicated modest decline for Q2 2025, reflecting supplier discounts to maintain order volumes amidst slow movement in downstream therapeutic and dietary supplement sectors.
• The Magnesium Acetate Tetrahydrate Production Cost Trend remained flat across European plants due to localized sourcing efficiencies and controlled acetic acid input costs.
• European buyers showed reduced urgency in bulk procurement throughout the quarter, waiting for clearer price signals amid ongoing macroeconomic caution.
• Distributors reported adequate inventory carryovers from Q1, discouraging fresh spot market purchases and putting downward pressure on market pricing.
• The Magnesium Acetate Tetrahydrate Demand Outlook across Europe remained lukewarm as there were no significant institutional tenders or seasonal health supplement drives influencing consumption.
• Production activity in regional facilities was steady but output was moderated slightly to avoid overstocking, leading to manageable pipeline inventory throughout Q2.
• Logistics within the EU remained smooth with efficient containerized transport, although minor disruptions due to localized regulatory checks were noted in May.
• Why did the price change in July 2025? The Price Forecast for July 2025 is slightly bullish as buyers will likely initiate fresh contracting before seasonal formulation peaks, leading to a cautious upward correction in the Spot Price.
For the Quarter Ending March 2025
North America
In the first quarter of 2025, the Magnesium Acetate Tetrahydrate market in North America showed a slightly mixed tone. There was no sharp movement in pricing, but mild pressure was seen from the buying side. Although figures showed limited fluctuation, market indicators suggest that price levels either held firm or showed a mild downward adjustment.
Procurement activity was cautious, with buyers sticking to planned orders. Demand from pharmaceuticals and personal care remained in place but was not aggressive. Many buyers were managing with existing inventories, so there was no urgency in the market. The overall sentiment stayed balanced, with no strong upward or downward push. Logistics were smooth, and seasonal transition across the region did not affect supply lines.
Although tariff measures remained in place, they did not exert any noticeable impact on the market during the quarter. Most suppliers adjusted their quotes based on available stock rather than any raw material pressure. Since Acetic Acid prices were steady, there was no cost-driven momentum in the market. The overall tone of Q1 remained quiet, shaped by routine trade and stable market behaviour across key segments.
Asia Pacific
In Asia Pacific, the average price of Magnesium Acetate Tetrahydrate declined by 1.23% during the first quarter of 2025. The fall was not steep, but it reflected a soft undertone in the market. The Chinese Lunar New Year fell in February, which affected production and shipments for a brief period. However, most suppliers had prepared in advance, and inventory levels were managed well. Procurement was planned, and buyers did not rush orders.
Demand from downstream sectors like pharmaceuticals, nutraceuticals, and food processing was steady but not strong. The seasonal shift in the region also played a role in maintaining subdued activity. Since Acetic Acid, a key raw material, remained price-stable during the quarter, there was no cost pressure seen from upstream. Suppliers kept their offers flexible, especially in March, to ensure steady offtake.
Logistic operations returned to normal after the holiday period and no major delays were seen in regional exports. Overall, the market was calm with soft demand and disciplined procurement, which led to a slight dip in average prices over the quarter.
Europe
In Europe, the Magnesium Acetate Tetrahydrate market showed little volatility during the first quarter of 2025. Prices appeared to be mostly stable with a soft inclination towards the lower side. The change was not sharp, but market feedback suggested slight easing in prices in some parts.
Demand from downstream industries like pharmaceuticals and food-grade applications stayed modest. Buyers did not place bulk orders and preferred to move with short-term requirements. Inventories were well maintained and helped avoid any sudden spot buying. With raw material costs like Acetic Acid holding stable, there was no push from the supply side either. The logistics network worked smoothly throughout the quarter. There were no reported delays in domestic or regional deliveries.
Market players maintained regular purchase activity, and sellers kept quotes consistent. A few traders offered slightly discounts to support movement, but the general price trend stayed flat to slightly soft. Overall, the quarter passed without any aggressive pricing action. Market sentiment stayed neutral and was guided more by regular trade flow than by cost or demand pressure.
For the Quarter Ending December 2024
North America
The North American Magnesium Acetate Tetrahydrate market demonstrated resilience in Q4 2024 despite navigating a challenging economic environment shaped by evolving supply chain dynamics and robust industrial demand.
Moderate supply constraints, driven by limited domestic production and periodic import disruptions, influenced market performance. However, the manufacturing sector showcased remarkable adaptability, focusing on supply chain optimization, automation of processes, and strategic cost management to sustain growth potential.
Key downstream industries, including food processing, pharmaceuticals, and personal care, maintained strong consumption levels, ensuring market stability. Strategic inventory adjustments and adaptive pricing strategies helped balance temporary supply-demand mismatches, further highlighting the market's ability to recalibrate in response to economic fluctuations.
Consistent demand across critical sectors, coupled with technological advancements, underscored the structural strength of the Magnesium Acetate Tetrahydrate market. This adaptability and strategic importance within advanced manufacturing supply chains position the market for continued growth in the future. Overall, the sector's resilience and innovation emphasized its vital role in supporting industrial value chains across North America.
Asia
Mixed performance with initial bearish trends stabilizing into a bullish market driven by strategic supply shifts and rising demand. The Magnesium Acetate Tetrahydrate market witnessed contrasting trends in Q4 2024. October saw significant price declines due to oversupply, reduced exports from China, and weak downstream demand. High inventories and falling acetic acid prices further pressured the market, with sluggish trading in Jiangsu and North China and stabilized conditions in South China.
November continued the bearish trend, with strategic supply adjustments and destocking driving prices lower, despite steady demand and favorable raw material costs. However, December marked a sharp market reversal as Chinese manufacturers curtailed production and exploited depleted inventories to reset pricing mechanisms, pushing prices significantly higher. Rising acetic acid costs, driven by robust downstream demand and increased input expenses, supported this shift.
Additionally, government stimulus and strong consumer activity bolstered manufacturing, particularly in automotive and electrical machinery, contributing to positive market sentiment. These factors, combined with expanding Christmas sales, indicate sustained economic growth for the quarter. Overall, Q4 reflected a critical transformation, setting the stage for a structurally rebalanced market.
Europe
The European Magnesium Acetate Tetrahydrate market in Q4 2024 faced significant volatility and strategic challenges, reflecting a highly dynamic pricing landscape. Increased reliance on Chinese imports, escalating freight costs, and fluctuating energy prices created a complex environment, requiring traders to adopt advanced inventory management and procurement strategies.
Despite these pressures, downstream sectors such as food additives and pharmaceuticals demonstrated resilient growth, as businesses carefully navigated rising operational costs amid uncertain demand signals. Mid-quarter, European markets capitalized on opportunities presented by Chinese suppliers clearing inventories through competitive pricing, enabling opportunistic trading strategies.
However, stringent regulatory compliance and quality control requirements added further complexity, emphasizing the importance of strategic market insight and proactive adjustments to evolving dynamics. The quarter showcased the critical need for adaptability as European traders balanced cost management and demand uncertainty while leveraging short-term pricing advantages. This strategic response underscores the evolving nature of the market and its capacity to navigate volatility with resilience and foresight.
For the Quarter Ending September 2024
North America
During the third quarter of 2024, the US Magnesium Acetate Tetrahydrate market exhibited distinct pricing patterns, heavily influenced by trans-Pacific shipping dynamics and domestic inventory management strategies. The market saw upward price pressure due to increased import costs, including higher container freight rates from China and extended port clearance times. Domestic distributors worked to maintain optimal inventory levels while managing increased carrying costs.
Import volumes showed moderate growth, though buyers remained cautious due to volatile shipping costs and extended lead times. The market experienced additional pressure from domestic logistics challenges, including inland transportation costs and warehouse capacity constraints. Mid-quarter, prices saw a temporary decline as Chinese suppliers offered competitive rates to maintain market share, prompting strategic buying from US importers.
Prices strengthened toward the end of Q3 as businesses began pre-winter stocking, particularly in regions expecting severe weather conditions. The pharmaceutical and food processing sectors increased their procurement activities, anticipating higher demand during the upcoming flu season and holiday period. The quarter concluded with a complex pricing environment shaped by import dependencies, logistics challenges, and seasonal demand patterns, requiring market participants to maintain flexible procurement strategies and robust inventory management practices.
Asia
Throughout the third quarter of 2024, the Magnesium Acetate Tetrahydrate market in the APAC region exhibited a stable pricing environment, characterized by minimal fluctuations. This stability was primarily driven by increased demand from downstream industries, consistent production levels, and balanced supply and demand dynamics, alongside stable raw material costs. Despite this equilibrium, the market experienced periods of intensified activity, marked by a surge in bulk procurement and higher inquiry volumes, contributing to heightened trading engagement.
Export trends from major producing nations showed steady growth as traders sought to enhance profit margins. However, challenges such as rising freight costs, particularly from China, dampened trading sentiment. The Acetic Acid market, crucial for Magnesium Acetate Tetrahydrate production, saw slight adjustments that fostered a cautiously optimistic outlook. Mid-quarter, a notable price decline occurred, influenced by seasonal factors as manufacturers cleared excess inventory from peak production, leading to oversupply and downward price pressure. Weakened downstream purchasing and budget reallocations further exacerbated this situation.
Conversely, a significant price escalation was observed as stakeholders engaged in anticipatory buying in response to production facility reopenings after August's shutdowns, driven by concerns over potential supply constraints. The approaching festive season and winter months, particularly in the food manufacturing and pharmaceutical sectors, increased demand, prompting companies to strategically restock. Overall, Q3 2024 for Magnesium Acetate Tetrahydrate reflected a dynamic landscape, with prices influenced by a mix of stable demand, seasonal adjustments, logistical challenges, and macroeconomic factors, necessitating careful navigation by industry participants.
Europe
Throughout the third quarter of 2024, the Magnesium Acetate Tetrahydrate market in Europe demonstrated notable price volatility, primarily influenced by its heavy reliance on Chinese imports and regional demand patterns. The market was characterized by increased procurement costs, driven by elevated freight rates on Asia-Europe routes and extended delivery timelines. The European market's pricing dynamics were further complicated by energy cost fluctuations, affecting storage and handling costs for importers.
Import activities showed measured growth as traders carefully balanced inventory levels against uncertain demand. Regulatory compliance costs and stringent quality control measures for imported materials added complexity to the trading landscape. The downstream demand, particularly from food additives and pharmaceutical sectors, maintained steady growth, though buyers showed resistance to higher prices. Mid-quarter, the market experienced temporary relief as Chinese suppliers offered competitive prices to clear inventory, leading to opportunistic buying by European traders.
However, prices rebounded sharply in late Q3 as European buyers increased their procurement activities in anticipation of winter demand and potential supply chain disruptions. The pharmaceutical sector's seasonal preparations for flu season strengthened demand, while food manufacturers increased their orders ahead of the holiday season. Overall, Q3 2024 in Europe was marked by careful inventory management, strategic buying patterns, and ongoing efforts to optimize supply chain efficiency amid global logistics challenges.
Frequently Asked Questions (FAQs):
1. What is Magnesium Acetate Tetrahydrate and where is it commonly used?
Magnesium Acetate Tetrahydrate is a white crystalline compound primarily used in pharmaceutical formulations, dietary supplements, food additives, and industrial catalysts. It serves as a magnesium source and buffering agent, especially in dermatological products, antacids, and electrolyte replacement therapies.
2. How is the global market price of Magnesium Acetate Tetrahydrate determined?
The price is influenced by factors such as feedstock costs (mainly acetic acid), regional production capacities, pharmaceutical and nutraceutical demand trends, export-import activity, and seasonal inventory cycles. Market quotes vary across regions like Asia-Pacific (FOB China), North America (FOB USA), and Europe (CIF Rotterdam).
3. What affects the demand outlook for Magnesium Acetate Tetrahydrate in the pharmaceutical sector?
Demand in the pharmaceutical industry is largely driven by seasonal formulation schedules, hospital inventory replenishment, OTC product demand (especially topical applications), and regulatory approvals for new magnesium-based formulations. Procurement patterns often align with quarterly production targets.
4. Are there any storage or handling considerations for Magnesium Acetate Tetrahydrate?
This compound is hygroscopic and should be stored in tightly sealed containers away from moisture and heat. Prolonged exposure to air can degrade product quality, making proper packaging and controlled storage conditions essential for bulk buyers.
5. Is there a difference between industrial and pharmaceutical grades of Magnesium Acetate Tetrahydrate?
Pharmaceutical-grade Magnesium Acetate Tetrahydrate undergoes higher purity checks and complies with pharmacopeial standards (e.g., USP, EP), making it suitable for human consumption and medicinal use. Industrial grades may not meet such stringent purity requirements and are typically used in technical applications.
